Supreme Court sides with pharmaceutical industry in two decisions

Justices rule that generic drug makers cannot be sued by injured patients in most cases and that drug manufacturers have a 1st Amendment right to buy private prescription records to use for marketing purposes.The Supreme Court rules that makers of generics, unlike makers of brand-name drugs, do not have to warn patients of newly revealed problems. In another ruling, justices supported drug makers buying or selling prescription records from patients for 'marketing' purposes.

Read the whole article on LA Times - Health

More from LA Times - Health